Adaptimmune to Present at Upcoming CAR-TCR Summit; CEO James Noble to be a Keynote Speaker – Nasdaq
Adaptimmune to Present at Upcoming CAR-TCR Summit; CEO James Noble to be a Keynote SpeakerNasdaqPHILADELPHIA and OXFORD, U.K., Aug. 30, 2017 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of TCR engineered T-cell th… Continue reading
